Brief: Endra Life Sciences Plans To Submit De Novo Request To U.S. FDA For Its Taeus® System In Coming Weeks
29/09/2022 21:06
Sept 29 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES PLANS TO SUBMIT DE NOVO REQUEST TO
U.S. FDA
FOR ITS TAEUS® SYSTEM IN COMING WEEKS
Source text for Eikon: ID:nBw5gDDJJa
Further company coverage: NDRA.O
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences